← back to search

Joshua Fein

Cornell University · US
Area of research
Hematology · Oncology
Research interest
Research interests include Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research, CAR-T cell therapy research, and Acute Lymphoblastic Leukemia research.
h-index
24
citations
2,380
works
100
NIH funding
primary concept
email

Recent publications

An inflammatory biomarker signature of response to CAR-T cell therapy in non-Hodgkin lymphoma
Nature Medicine 2025cited by 35position: middledoi
Chimeric antigen receptor T cell therapy in octogenarians with B cell lymphoma: a real-world US multicenter collaborative study
Bone Marrow Transplantation 2025cited by 9position: middledoi
Absolute lymphocyte count after BCMA CAR-T therapy is a predictor of response and outcomes in relapsed multiple myeloma
Blood Advances 2024cited by 29position: middledoi
CD19-directed CART therapy for T-cell/histiocyte–rich large B-cell lymphoma
Blood Advances 2024cited by 19position: middledoi
Donor KIR genotype based outcome prediction after allogeneic stem cell transplantation: no land in sight
Frontiers in Immunology 2024cited by 12position: middledoi
Outcomes of first therapy after CD19-CAR-T treatment failure in large B-cell lymphoma
Leukemia 2022cited by 99position: middledoi
Patterns of salivary microbiota injury and oral mucositis in recipients of allogeneic hematopoietic stem cell transplantation
Blood Advances 2020cited by 62position: middledoi
Outcomes of allogeneic haematopoietic stem cell transplantation from HLA-matched and alternative donors: a European Society for Blood and Marrow Transplantation registry retrospective analysis
The Lancet Haematology 2019cited by 219position: middledoi
The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy
Nature Communications 2017cited by 179position: middledoi
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Blood 2016cited by 287position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Roni Shouval · University of Minnesota Medical Center3 papers (2019–2024)Arnon Nagler · University of Naples Federico II2 papers (2019–2020)Adrian Wiestner · National Institutes of Health1 papers (2017–2017) · 1 papers (2020–2020)Samir Parekh · Mount Sinai Hospital1 papers (2024–2024)Alex F. Herrera · City Of Hope National Medical Center1 papers (2024–2024)Suzanne Lentzsch · Columbia University Irving Medical Center1 papers (2024–2024)Amir A. Kuperman · Hebrew University of Jerusalem1 papers (2020–2020)Craig S. Sauter · Medical College of Wisconsin1 papers (2024–2024)Mateo Mejía Saldarriaga · Cornell University1 papers (2024–2024)Thomas J. Kipps · Moores Cancer Center1 papers (2016–2016)Caron A. Jacobson · Harvard University1 papers (2016–2016)Arnold S. Freedman · Harvard University1 papers (2016–2016)Myriam Labopin · Inserm1 papers (2019–2019)Chingiz Underbayev · National Heart Lung and Blood Institute1 papers (2017–2017)Shambavi Richard · Icahn School of Medicine at Mount Sinai1 papers (2024–2024)Haesook T. Kim · Harvard University1 papers (2016–2016) · 1 papers (2020–2020)Catherine J. Wu · Dana-Farber/Harvard Cancer Center1 papers (2017–2017)Adriana Rossi · Instituto Cardiovascular de Buenos Aires1 papers (2024–2024)